Blog

Guest Post: Scott Estrin on #DiabetesAccessMatters

We will be sharing stories about access and the issues patients have encountered in getting the diabetes supplies, medications, and services they need. Scott, advocate blogger at Rolling in the D,  gives his thoughts and comments about access by sharing his story.


image1Last year, I tried (unsuccessfully) to upgrade to a new insulin pump/CGM combination. My insurer was known for denying such requests as they were deemed “experimental”, but I believed to have sufficient justification so I pursued trying to obtain the device.

Pump Denial

My first battle was with the manufacturer itself, who knew that this claim would be denied and didn’t want to participate in the battle – I was encouraged not to fight it and to simply buy the pump outright, in all cash. I refused, and instructed the representative to submit the authorization-request to my insurance. A month goes by, and I found out that the representative ignored my wishes and did NOT submit it, because she knew it would be denied; it seemed she couldn’t be bothered with the hassle.

After finally getting the authorization-request submitted, I got a denial in the mail, as expected. The denial letter instructed me how I could appeal, and separately how I could obtain information used in which to reach the conclusion of a denial. The appeal would have been rather useless without knowing the basis of the denial, so I made that request. After months went by without a response, I attempted, numerous times, to call my insurance company. I was transferred to fast-busies and disconnections, and referred to call incorrect phone numbers.

Eventually, I had to choose the automated options to identify myself as a healthcare provider, and then to plead with the representative not to transfer me back to the black hole I had been in previously. Eventually, after re-sending my request, I got the information in the mail.

The basis for the denial was rather weak.  My endocrinologist chose not to participate in the appeal-process. His role is to practice medicine, not to process insurance appeals. I could accept his reasoning, and knew that I could formulate a strong appeal on my own. I rebutted it, point-by-point, in a nine page letter with documentation to back up each one of my assertions.

Appeal with Published Data

My appeal was based on quantifiable fact and written, published data — not on pleas or emotion. I was denied again, for the same indefensible reason. But by this time, I’d had enough. The process was so time-consuming and mentally draining, that I chose not to continue with the appeal process.

I felt defeated, knowing that “the system” won; however the relief I felt at finally closing the book on my appeal-process counterbalanced that feeling of defeat. Fortunately, during this time I had found an alternate product that made me equally, if not more, happy. Next time, I may not have that alternative. That is why I am telling this story.

Doctors are trained to prescribe medical treatments. Insurers aren’t. When insurers contradict the professional, trained opinions of the professionals who provide care, they threaten the health and well-being of their clients. That is not acceptable and the practice has to be stopped.


Scott has been living with Type 1 diabetes for 35 years. Described by his friends as “always thinking”, he constantly seeks to understand why things are the way they are and how they can be made better. Though diabetes is a part of his life, he does not let himself become consumed by it; that honor goes to his wife, his two sons, and his love for ice hockey, of which he is a youth-team coach. Scott and his family live in New Jersey.


access_™ 612x300If you would like to share your story about access and why #diabetesaccessmatters to you and your family, please do so here. Our voices and our stories are powerful. Share yours.

May Thank You Tweets

Say Thanks!

DPACActNowBubbleIt is good manners to say thanks when an elected officials co-sponsor bills that help people with diabetes. It also helps them know we are paying attention.

Here’s a list of people who have recently co-sponsored a bill this month. To say “Thank You.” Just click to Thanks! Tweet.

Want to see more than just May’s bill co-sponsors? Click ACT NOW DPAC for our scorecard to tweet any or all the cosponsors.

Diabetes Clinical Care Commission Act

  • Thanks! Sen. Vitter, David [R-LA] 5/23/2016
  • Thanks! Sen. Menendez, Robert [D-NJ] 5/19/2016
  • Thanks! Rep. Walden, Greg [R-OR-2] 5/19/2016
  • Thanks! Rep. Blum, Rod [R-IA-1] 5/18/2016

Medicare CGM Access Bill

  • Thanks! Rep. Butterfield, G. K. [D-NC-1] 05/25/2016
  • Thanks! Rep. Boustany, Charles W., Jr. [R-LA-3] 05/24/2016
  • Thanks! Sen. Udall, Tom [D-NM] 05/23/2016
  • Thanks! Sen. Burr, Richard [R-NC] 5/12/2016
  • Thanks! Rep. Posey, Bill [R-FL-8] 5/10/2016
  • Thanks! Rep. Cook, Paul [R-CA-8] 5/10/2016
  • Thanks! Rep. Richmond, Cedric L. [D-LA-2] 5/10/2016
  • Thanks! Sen. Carper, Thomas R. [D-DE] 05/16/2016

Diabetes Education

  • Thanks! Rep. Maloney, Carolyn B. [D-NY-12] 05/17/2016

Guest Post: Asha Brown on #DiabetesAccessMatters

We will be sharing stories about access and the issues patients have encountered in getting the diabetes supplies, medications, and services they need. Asha Brown, founder of We Are Diabetes gives her thoughts and comments about access by sharing her story.


Asha Brown Diabetes Access MattersI’ve been a human pincushion (aka type one diabetic) since I was five years old. The sight of needles and blood is such a common theme in my life that sometimes it’s shocking to see a non-diabetic person get so uneasy when they see me plunge a syringe into my torso to give my body the synthetic hormone insulin, which keeps me alive.

Being entirely responsible for manually preventing yourself from dying each day is a lot to ask of a person. There’s a lot to calculate and plan. No matter how adept a type one diabetic is at knowing their insulin to carb ratio, how their body responds to exercise and stress etc., there are always factors outside of our control that spiral our diabetes management out of control. Day in and day out we do the very best we can to manage a disease that tries to kill us, and try to find stability despite a long list of factors that constantly keep us out of balance.

Getting the supplies that we need to STAY ALIVE should not be one of the factors on that list.

Over the 26 years I’ve lived with type one diabetes (and other autoimmune diseases I was diagnosed with as a result of T1D) the most stressful factor I’ve had to continuously deal with is my insurance denying or restricting medications that are essential to my diabetes management.

Insurance Denying Access

Most recently I had to fight to have my 24 hour insulin distributed to me in the proper amounts. My insurance wanted me to make one bottle last for 3 months. There are a number of reasons why this was a ridiculous restriction:

  1. Insulin loses its effectiveness/expires once the bottle has been open for 30 days
  2. I need more 24 hour insulin to KEEP ME ALIVE than is included in one bottle.
  3. The USA is not a third world country rationing toilet paper and reusing tinfoil due to a shortage of everything that exists. There’s plenty of Lantus to go around. I spent hours on the phone for over a week before this issue was rectified and I was “allowed” to have the very necessary 3 bottles of insulin I need to last me for 90 days.

I have been through four different situations of medications being denied, year after year. Every time this happens I go through the appeals process, and I get my doctors support with all the proper paperwork, and eventually get my medication.

The amount of superfluous hoops I am forced to jump through just to get the medications I need causes unbelievable (and unnecessary) stress for me, on top of the stress of living with a demanding life long chronic illness. I didn’t get a choice in being diagnosed with type one diabetes, but I should be allowed to have the choice of how I manage it.


access_™ 612x300If you would like to share your story about access and why #diabetesaccessmatters to you and your family, please do so here. Our voices and our stories are powerful. Share yours.

How to Tweet Your Way To Diabetes Advocacy Success

TweetTwitter has been described as a social media cocktail party. You can drift in and out of conversations, get news that matters to you, and raise your glass (and your voice) to those who inspire (or incense) you. For those who want to let policy makers (and others) know about the importance of diabetes policy advocacy, Twitter is a powerful tool for amplifying our voices.

Want to use Twitter as a Powerful Advocacy Tool?

Let’s walk (or fly) you through it.

  1. If you don’t have one, get a Twitter account. (It’s not hard, but it does take a little time to set up. Twitter has a great step-by-step process to get you started. Once you’ve gotten your account set up (congrats!), you’ll want to learn a little more about getting the most out of this great social media tool.
  2. Follow @DiabetesPAC. (We’ll give you the latest diabetes policy advocacy right on your Twitter feed.)Great tip on getting interesting accounts to follow on Twitter
  3. Once you’ve followed a few interesting Twitter accounts (beyond @DiabetesPAC, of course), it’s time to tweet and retweet and connect with others about diabetes advocacy. How?
  4. Start by sending this tweet:
Hey @diabetespac, I want to help change #diabetes policy. I'm a DPAC Insider! Click To Tweet

and then you can send this tweet:

I advocate for people with #diabetes. @CMSGov needs to #suspendbidding for their testing supplies now. http://bit.ly/1TIs9qs Click To Tweet

The Pound Sign (Or “Hashtag” in Social Media!)

This sign: # is important. It can help you find tweets about a topic and connect you to like-minded individuals who are as passionate about that topic. If you search for #diabetes in the Twitter search box, you’ll get all sorts of good (and not so good) Tweets about diabetes. It’s important to focus on the good Tweets. You’ll save time trying to right wrongs on the Internet this way!

Here are some suggestions for diabetes focused events that can help you dip your toe into engaging on Twitter: #dsma and #dcde – these are weekly Twitter chats that happen on Wednesday and Tuesday nights respectively. Each week, a topic is given and questions are asked – and anyone can answer and get involved.

For diabetes policy advocacy, you’ll look for #suspendbidding and #vote4diabetes to get your feet wet. You’ll see what has been going on and what will be happening in the future.

The DPAC Scorecard

DPAC ScorecardNow that you’ve gotten your Twitter account up and running, hop on over to the DPAC Scorecard and start your Twitter diabetes policy advocacy. (Once you do this, you’ll understand how easy diabetes policy advocacy is with DPAC.)

  • Find your state.
  • Find your representatives.
  • Across the top of the grid, you’ll see the bills that are important for the diabetes community – and next to your representatives’ names will be a “Thanks” or a “Please” – clicking those “Thanks” and “Please” will send a tweet to your representative’s Twitter handle and let them know that diabetes matters to you – a voting constituent.
  • Tweet a few pre-populated messages to your representatives right now.

Quick, wasn’t it? You just advocated for people with diabetes from your computer.

Another great feature of the DPAC Scorecard: When you click on your representatives’ names, you’ll also be able to tweet an important statistic – how many people with diabetes are in their district and how important it is to listen to them.

Tweet-Ins

As a diabetes policy advocate, you know that more voices speaking in unison = powerful messages. That’s why we believe in Tweet-Ins = a concentrated Twitter campaign that focuses on a particular issue at a particular time. (Why is it called a Tweet-In? Because it’s like a “sit-in” but we’re not leaving our computers or phone – but we are making a powerful statement in 140 characters or less.)

Imagine one tweeted message being sent to a Congressperson’s office. Now imagine 100 tweeted messages being sent on one day (or even a few hours)! That Congressperson is going to know how important this diabetes issue is for our community. That’s the point of a DPAC Tweet-In.

DPAC will be holding a Tweet-In on May 12th for the #SuspendBidding and #DiabetesAccessMatters campaigns and we hope you’ll join us with your Twitter account and your passion for diabetes policy advocacy.

We’ll be sending out information and what you’ll need to do with your Twitter handle – but know that it will be easy, because that’s what DPAC is all about – making diabetes policy advocacy easy for everyone.

But for right now, you can help by tweeting this:

Want to get the latest news on #diabetes advocacy? Follow @diabetespac and be a DPAC Insider! Click To Tweet

Can A Single Tweet Save A Life?

Tweet

Tweet-In May 12th, 2016 at 8pm EST

[separator style_type=”shadow” top_margin=”40″ bottom_margin=”40″ sep_color=”” icon=”” width=”” class=”” id=””]

TweetOn Thursday, May 12, 2016 at 8pm EST, we are asking our diabetes community (And those who care about people with diabetes!) to band together and send a message to Congress and others that restricting access to diabetes medications, devices, and supplies harms people.

Diabetes is self-managed and everyone’s management is individualized.  Patients and their healthcare teams should define the best path for living well with diabetes. Government bureaucrats and insurance company cost accountants should not veto doctors’ orders.

These efforts do not always save even money. The Centers of Medicare and Medicaid Services’ (CMS) attempt to save money on diabetes testing supplies has actually done the opposite – money is being wasted on increased hospital stays. Not just losing money, but people with diabetes on Medicare in the US are losing their lives through this program. Send a tweet to help save a life.

To learn more about the CMS Competitive Bidding Program and why it needs to be immediately suspended, click here. We have a campaign called #suspendbidding and we want to get Congress to care.


A single tweet can save a life.

Imagine what 10,000 tweets can do.


Thursday, May 12th DPAC Tweet-In

#Vote4Diabetes #SuspendBidding #DiabetesAccessMatters

DPAC_Tweet_In_MayStarting on May 12, 2016 at 8pm EST, we ask you to pick up your Twitter account and swing into action, hitting each of your representatives in Congress with twitter messages about diabetes.   Here’s the step-by-step simple actions you’ll take.

  1. Click here to open the DPAC Scorecard.
  2. Scroll down to your state. You’ll find your Senators’ and your Representative’s names listed on the left side. (Don’t know who your representative is? No problem. Click here.)
  3. Click on those representatives’ names. A pre-populated message will tell your Congressional representatives via your Twitter account that they need to #suspendbidding immediately and a link for more info. (It will also tell them how many people in their district have diabetes… a gentle reminder that there are a lot of us.)
  4. Click that TWEET button. It will send a tweet from your account.
  5. Easy, right? Do it two more times for a total of three messages (two to your Senators and one to your House Representative). You’re done for the #suspendbidding. High Five!
  6. Then click the links on the scorecard for other diabetes issues and send MORE messages to Congress about diabetes policy issues.
    • • Just don’t click and send rapid-fire. You could end up in Twitter Jail. This is a real thing and it has happened to some of our diabetes advocates in previous Tweet-Ins! If you send over 100 tweets in an hour, you’ll be prevented from sending any more.

#DiabetesAccessMatters

  1. There are also access issues in the news with a large insurance company restricting access of durable medical equipment based on cost savings.

You can click on this to send a message:

Docs & patients should choose best treatments. Not @myUHC. #DiabetesAccessMatters #Vote4Diabetes Click To Tweet

In fact, you can click on this right now. You don’t even need to wait for the 12th. Go ahead. We’ll wait.

Wait! You Can Do More!

You can also send these messages, too.

Simply click these on May 12th, 2016 at 8pm.

(And you can click these anytime after the Tweet-In, too.) 

.@CMSGov program ⇧ costs & deaths. #FAIL Learn more. http://bit.ly/1SLLhBH #SuspendBidding #Vote4Diabetes Click To Tweet .@CMSGov restricting access at the cost of lives. #SuspendBidding #Vote4Diabetes http://bit.ly/1SLLhBH Click To Tweet Hey @askUHC You think you know better than my doc what is best for me? #MyPumpMyChoice #Vote4Diabetes Click To Tweet ➕ deaths? ➕ money? ➖ access? @CMSGov #suspendbidding #Vote4Diabetes: http://bit.ly/1SLLhBH Click To Tweet

Tell your friends about the DPAC Tweet-In (click below to share!) and mark your calendars.

On Thursday, May 12th at 8pm, your tweets will save lives.

Join me on Thursday, May 12th at 8pm EST. DPAC Tweet-In. Help save lives of people with #diabetes. Click To Tweet

Don’t forget to follow @DiabetesPAC on Twitter for more information about the DPAC Tweet-In and the latest updates. 

DPAC tweetin 612x300

Special Diabetes Program

What is the FDA?

 

FDA_Sign_&_Bldg_21_at_Entrance_(5204602349)The Food and Drug Administration (FDA), with over 30 different divisions and offices, is responsible for overlooking the safety and efficiency of drugs, medical devices, food and other biological products for the United States public. For people with diabetes, the FDA plays a very important role. They oversee the safety of the drugs that a person with diabetes may have to take, whether it is injectable or oral and the safety of current and newly developed medical devices. (Like blood glucose meters and insulin pumps!)

What are the Important Diabetes Related Divisions within the FDA?

The two divisions of the FDA most important to people living with diabetes are The Center for Drug Evaluation and Research (CDER) and The Center for Devices and Radiological Health (CDRH).

The Center for Drug Evaluation and Research (CDER)

CDER’s primary focus is to ensure that people living within the United States have safe and effective drugs available to them in order to help improve their health. This includes over-the-counter and prescription drugs. For people with diabetes,  all insulin, diabetes oral medications, glucagon, and other medications.

There are a few initiatives from within the CDER office that are worth nothing:

Critical Path Initiative

The Critical Path Initiative is the FDA’s method of creating a streamlined process of how FDA-regulated products move from a development phase to the consumer more efficiently. You can learn more about the Critical Path Initiative here.

Safe Use Initiative

The Safe Use Initiative from the FDA is a long-term program to help ensure that people are safely and properly taking medications. The goal of the initiative is to decrease the amount of medication misuses and errors by eliminating the wrong doses or medications being prescribed and filled by doctors and pharmacies, as well as educating the public on how to properly take their medications.

Safety First Initiative

The Safety First Initiative was put in place to ensure that an on-going review of a drug is continued throughout its lifecycle.

The Center for Devices and Radiological Health (CDRH)

The CDRH’s primary focus is to assure consumers and patients are provided safe and effective medical devices. This includes blood glucose monitoring devices, insulin pumps, continuous glucose monitoring systems, and artificial pancreas device systems. The CDRH includes a Medical Device Advisory Committee which advises the Commissioner about safety related items in regards to medical devices.

Partner with Patients

One of the 2016-2017 Strategic Priorities for the CDRH is to Partner with Patients. The goal is to work with patients to help the development and evaluation of new devices.

We believe that if CDRH is to successfully achieve a mission and vision in the service of patients, we must interact with patients as partners and work together to advance the development and evaluation of innovative devices, and monitor the performance of marketed devices – FDA

The CDRH has created an advisory committee whose sole purpose is patient engagement. This has never been done before in the history of the FDA. Learn more here about the Patient Engagement Advisory Committee.

The CDRH has also created the Digital Health Program which focuses on developing and utilizing modern technologies to help create better health outcomes.

How Does the Diabetes Online Community Work With FDA?

#DOCasksFDA

On Monday, November 3, 2014, the Diabetes Online Community (DOC) was involved in a discussion with the FDA. This meeting included nearly 30 people on site just outside of Washington, D.C. and, according to the FDA, more than 1,000 attendees online. During this meeting there were discussions about test strip safety, diabetes related data, patient stories, and more diabetes hot topics.

This event showed how a community can come together to advocate for a disease. In fact, so many people showed up at once that is temporarily crashed the FDA’s servers!

On this day, the DOC made its voice heard and the FDA listened. We can continue to do this by acting now.

StripSafelySS-LOGO-STACK-SM

StripSafely was created to help the general public understand that there are, unfortunately, inaccurate blood glucose test strips and meters currently on the market. The inaccurate results from these devices can be life threatening. For example, injecting insulin based off of an inaccurate test result can cause a person’s blood sugar to drop significantly and quickly. The real work of StripSafely has come from the amazing members of the Diabetes Online Community. StripSafely would love to see the letters or posts you have written about the safety and accuracy of blood glucose monitoring devices.

On Wednesday, August 21 2013, StripSafely staged a Tweet-In which asked Congress to send aides to an upcoming Diabetes Technology Meeting. The response from the DOC was enough to start catching the eye of the FDA.

Over the next few weeks, we’ll be asking you to take action to help the FDA ensure the safety, quality, and access of diabetes medications and devices.

 

DPAC Insiders: The State of Diabetes Policy – 2nd Quarter 2016

 

DPAC Insiders Policy AdvocacyDo you know what the statuses are of the diabetes bills on Capitol Hill? What’s going to happen in this election year for diabetes policy? Are law makers even listening to the diabetes community?

Find out all of this and more during the DPAC Insiders: The State of Diabetes Policy Second Quarter 2016 online event on May 12, 2016 at 12pm Eastern.

Register here for DPAC Insiders. 

What Topics Will Be Covered?

We’ve got the latest from the DPAC Scorecard, the latest on the bills currently on the Hill, what bills have recently been introduced that we’ll be watching, upcoming events and opportunities to advocate, and ways to reach lawmakers that might be a little…unconventional. You’ll have an opportunity to ask questions and get answers during this interactive event. You’re part of DPAC – we want to hear from you.

Who are DPAC Insiders?

You. Your friends. Your family members. Your community. Anyone who wants to help amplify the voice of diabetes policy. By registering for this event, you’ll get the “inside track” and be in the know – and get the latest updates when things heat up on the Hill.

DPAC Insiders voices make a difference and you’ll hear how during the upcoming event. Join us and get the “inside scoop” on May 12, 2016 at 12pm Eastern. 

How Can You Help Right Now?

Simple. Share this post and tweet the registration link using the Click To Tweet below.

We’ll see you there!

Join us on May 12 at 12pm Eastern for DPAC Insider & get the inside scoop for #diabetes advocacy. Click To Tweet

Replay: Ask An Expert: Tom Karlya

Tom “Diabetes Dad” Karlya joins DPAC to share the success of Reegan’s Rule in North

DPAC_ASKanEXPERT_TK PlayCarolina as a precedent for other states.

Why we’re excited.

Tom knows that advocacy happens when people act and where they act. He will share the heartbreak that drove the creation of Reagan’s Rule and how we can honor the children who have been lost to a lack of a timely diagnosis of Type 1 diabetes by working with our state legislatures.

Children with Type 1 diabetes are being missed; their symptoms are dismissed as flu/virus initially; causing extended hospital stays, enormous loss of workdays, incredible family hardship and in some instances, severe brain damage and death in children needlessly.

Learn what has worked.

View the archived recording of this important presentation here.

Of Test Strips, Bidding, and Harm

ACT NOW: Find the Truth About Medicare Test Supply Bidding.

Test strips are the foundation of good diabetes self-care. People with diabetes, particularly those who use insulin, need to test frequently to manage their blood glucose and make care adjustments, particularly with the insulin. As simple as it sounds test strips are vital to avoiding dangerous low blood sugars from insulin.

Insulin can be a dangerous drug. An article in the Journal of the American Medical Association estimates that ninety-seven thousand of Americans a year go to the emergency room due to low blood sugars caused by insulin.(1) The journal goes on to says most of those insulin ER visits are seniors, Medicare’s people. Further the article says that one in three of the ER visits the person is hospitalized. When insulin is dangerous, it is expensive.
jama cost nap

 

The ninety-seven thousand mentioned cited in that article is MORE than the government estimate of Americans who go to the ER for stimulants including methamphetamines.(2) It is shocking that insulin beats Breaking Bad as a reason Americans go to the ER.

However, the comparison does help put good self-management in perspective. Clearly a goal is the safe use of insulin that helps keep Americas well, particularly seniors. Quality of life and cost are both better if we can prevent the need for emergency room visits and avoiding unnecessary hospital admissions expenses to Medicare.

 

madness

We all have heard of medical trials. Trials, because they can impact the participant’s health, have strict rules. Some of those rules came about as the result of studies that were unethically done on people without their permission or knowledge.(3) It seems logical that if someone were going to introduce new means of accessing something as critical to maintaining health as test strips that they would follow the trails safety rules.

Unfortunately, that was not the case.

Medicare changed the rules for how beneficiaries get test strips. Medicare tested it in 2011 in nine pilot cities around the country. But they didn’t treat it as a trial or follow safe protocols. Maybe because they judged the rules don’t apply to them as a government agency. Medicare said it was a huge success, they saved money and there were few complaints and no disruption.

An article in Diabetes Care, the Journal of  American Diabetes Association,  looked carefully at Medicare’s data. It showed that in the nine pilot cities(4) there was a disruption of patients access to test strips. How and how many strips people with diabetes acquired shifted. In some cases, people on insulin stopped receiving testing supplies. The researchers found an increase in hospitalizations, higher cost, and more mortality in people with diabetes using insulin in the test cities.

I don’t know who is right, Medicare, who says there was no harm and extended the program nationwide or the researchers who found statistically significant increase in mortality, hospitalization, and costs in Medicare’s data. I am not a scientist, a statistician or a bioethicist. I do want to know if people on Medicare are safe.

Congress is paying the bills. They authorized this experiment. They should find out what the truth is and tell us is Medicare program safe? ACT NOW to ask Congress to get to the truth.

Links and resources on CMS Bidding.

(1) Geller AI, Shehab N, Lovegrove MC, et al. National Estimates of Insulin-Related Hypoglycemia and Errors Leading to Emergency Department Visits and Hospitalizations. JAMA Intern Med. 2014;174(5):678-686. doi:10.1001/jamainternmed.2014.136. https://archinte.jamanetwork.com/article.aspx?articleid=1835360
(2) National Institute on Drug Abuse. Drug-Related Hospital Emergency Room Visits Retrieved from http://www.drugabuse.gov/publications/drugfacts/drug-related-hospital-emergency-room-visits
(3) https://en.wikipedia.org/wiki/Belmont_Report
(4) Test sites included Charlotte-Gastonia-Concord (North Carolina and South Carolina); Cincinnati-Middletown(Ohio, Kentucky and Indiana); Cleveland-Elyria-Mentor (Ohio); Dallas-Fort Worth-Arlington (Texas); Kansas City(Missouri and Kansas); Miami-Fort Lauderdale-Pompano Beach (Florida); Orlando (Florida); Pittsburgh(Pennsylvania); and Riverside-San Bernardino-Ontario (California)

 

Thank You

Say Thanks!

DPACActNowBubbleAll of our efforts of reaching out to our elected officials to ask them to sponsor or co-sponsor bills that help people with diabetes matter. So does saying Thanks when they actually do it.

This list below is an on-going list of people who have recently co-sponsored a bill it worth taking the time to say, “Thank You.” Just click to Thanks! Tweet.

Medicare CGM Access Bill

House

  • Thanks! Rep. Posey, Bill [R-FL-8] 5/10/2016
  • Thanks! Rep. Cook, Paul [R-CA-8] 5/10/2016
  • Thanks! Rep. Richmond, Cedric L. [D-LA-2] 5/10/2016
  • Thanks! Rep. Edwards, Donna F. [D-MD-4] 4/28/2016
  • Thanks! Rep. Miller, Candice S. [R-MI-10] 04/27/2016
  • Thanks! Rep. Huizenga, Bill [R-MI-2] 04/27/2016
  • Thanks! Rep. Long, Billy [R-MO-7] 04/27/2016
  • Thanks! Rep. Johnson, Eddie Bernice [D-TX-30] 04/26/2016
  • Thanks! Rep. Renacci, James B. [R-OH-16] 04/26/2016
  • Thanks! Rep. Blackburn, Marsha [R-TN-7] 04/26/2016
  • Thanks! Rep. Crowley, Joseph [D-NY-14] 04/26/2016
  • Thanks! Rep. Young, Don [R-AK-At Large] 04/26/2016
  • Thanks! Rep. Wittman, Robert J. [R-VA-1] 04/19/2016
  • Thanks! Rep. Knight, Stephen [R-CA-25] 04/19/2016
  • Thanks! Rep. Napolitano, Grace F. [D-CA-32] 04/18/2016
  • Thanks! Rep. Kuster, Ann M. [D-NH-2] 04/18/2016
  • Thanks! Rep. McKinley, David B. [R-WV-1] 04/18/2016
  • Thanks! Rep. Jeffries, Hakeem S. [D-NY-8] 04/18/2016
  • Thanks! Rep. Hensarling, Jeb [R-TX-5] 04/18/2016
  • Thanks! Rep. Sarbanes, John P. [D-MD-3] 04/18/2016
  • Thanks! Rep. Takai, Mark [D-HI-1] 04/13/2016
  • Thanks! Rep. Lawrence, Brenda L. [D-MI-14] 04/13/2016
  • Thanks! Rep. Delaney, John K. [D-MD-6] 04/13/2016
  • Thanks! Rep. Hahn, Janice [D-CA-44] 04/12/2016
  • Thanks! Rep. Perry, Scott [R-PA-4] 04/12/2016
  • Thanks! Rep. Sanchez, Loretta [D-CA-46] 04/12/2016
  • Thanks! Rep. Sessions, Pete [R-TX-32] 04/12/2016
  • Thanks! Rep. Johnson, Sam [R-TX-3] 04/12/2016
  • Thanks! Rep. Poe, Ted [R-TX-2] 04/12/2016
  • Thanks! Rep. Gowdy, Trey [R-SC-4] 04/12/2016
  • Thanks! Rep. Buchanan, Vern [R-FL-16] 04/12/2016
  • Thanks! Rep. Rouzer, David [R-NC-7] 04/12/2016
  • Thanks! Rep. Mullin, Markwayne [R-OK-2] 04/12/2016
  • Thanks! Rep. McMorris Rodgers, Cathy [R-WA-5] 04/12/2016
  • Thanks! Rep. Comstock, Barbara [R-VA-10] 04/12/2016
  • Thanks! Rep. Neal, Richard E. [D-MA-1] 04/12/2016
  • Thanks! Rep. Murphy, Tim [R-PA-18]3/21/2016
  • Thanks! Rep. Duncan, John J., Jr. [R-TN-2]3/21/2016
  • Thanks! Rep. Luetkemeyer, Blaine [R-MO-3]3/21/2016
  • Thanks! Rep. Brooks, Susan W. [R-IN-5]3/21/2016
  • Thanks! Rep. Tipton, Scott R. [R-CO-3]3/17/2016
  • Thanks! Rep. Webster, Daniel [R-FL-10]3/17/2016
  • Thanks! Rep. Clay, Wm. Lacy [D-MO-1]03/16/2016
  • Thanks! Rep. O’Rourke, Beto [D-TX-16]03/16/2016
  • Thanks! Rep. Green, Gene [D-TX-29]03/16/2016
  • Thanks! Rep. Graham, Gwen [D-FL-2]03/16/2016
  • Thanks! Rep. Bishop, Rob [R-UT-1]03/16/2016
  • Thanks! Rep. Reichert, David G. [R-WA-8]03/15/2016
  • Thanks! Rep. Nadler, Jerrold [D-NY-10]03/14/2016
  • Thanks! Rep. Smith, Adam [D-WA-9]03/15/2016
  • Thanks! Rep. Bishop, Sanford D., Jr. [D-GA-2]03/14/2016
  • Thanks! Rep. Palazzo, Steven M. [R-MS-4]02/04/2016
  • Thanks! Rep. Watson Coleman, Bonnie [D-NJ-12]02/01/2016
  • Thanks! Rep. Salmon, Matt [R-AZ-5]02/01/2016
  • Thanks! Rep. Yoho, Ted S. [R-FL-3]01/12/2016
  • Thanks! Rep. Forbes, J. Randy [R-VA-4]01/08/2016
  • Thanks! Rep. Grayson, Alan [D-FL-9]01/08/2016

Senate

  • Thanks! Sen. Whitehouse, Sheldon [D-RI] 4/27/2016
  • Thanks! Sen. Mikulski, Barbara A. [D-MD]03/14/2016

National Diabetes Clinical Care Commission Bill

House

  • Thanks! Rep. Velazquez, Nydia M. [D-NY-7] 04/29/2016
  • Thanks! Rep. Rice, Kathleen M. [D-NY-4] 04/29/2016
  • Thanks! Rep. Babin, Brian [R-TX-36] 04/29/2016
  • Thanks! Rep. Brady, Robert A. [D-PA-1] 04/28/2016
  • Thanks! Rep. Walberg, Tim [R-MI-7] 04/28/2016
  • Thanks! Rep. Conyers, John, Jr. [D-MI-13] 04/28/2016
  • Thanks!  Rep. Kaptur, Marcy [D-OH-9]02/24/2016
  • Thanks! Rep. Rokita, Todd [R-IN-4]01/07/2016

Senate

  • Thanks! Rep. Rouzer, David [R-NC-7] 04/21/2016
  • Thanks! Rep. Miller, Candice S. [R-MI-10] 04/21/2016
  • Thanks! Rep. Van Hollen, Chris [D-MD-8] 04/21/2016
  • Thanks! Rep. Scott, “Bobby” [D-VA-3] 04/15/2016
  • Thanks! Rep. Zeldin, Lee M. [R-NY-1] 04/15/2016
  • Thanks! Rep. Perry, Scott [R-PA-4] 04/15/2016
  • Thanks! Rep. Jones, Walter B., Jr. [R-NC-3] 04/15/2016
  • Thanks! Rep. Deutch, Theodore E. [D-FL-21] 04/15/2016
  • Thanks! Rep. Duncan, John J., Jr. [R-TN-2] 04/15/2016
  • Thanks! Rep. Swalwell, Eric [D-CA-15] 04/15/2016
  • Thanks! Rep. Fitzpatrick, Michael G. [R-PA-8] 04/15/2016
  • Thanks! Rep. Thornberry, Mac [R-TX-13] 03/22/2016
  • Thanks! Sen. Boozman, John [R-AR]03/15/2016
  • Thanks! Sen. King, Angus S., Jr. [I-ME]02/23/2016

These are new cosponsors since January 1, 2016. Please ACT NOW and also send thanks to your elected officials who have sponsored or cosponsored before January 1, 2016.

If you do not see your officials on this list, then go to the Scorecard and find out if they have cosponsored or not.

Skip to toolbar